|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
108.07(B) |
Last
Volume: |
8,825,251 |
Avg
Vol: |
8,418,111 |
52
Week Range: |
$48.64 - $75.67 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
312,036 |
508,687 |
1,007,678 |
2,119,191 |
Total Sell Value |
$23,117,519 |
$34,902,586 |
$61,221,104 |
$110,722,184 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
27 |
44 |
79 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2022-12-13 |
4 |
AS |
$47.78 |
$3,787,234 |
D/D |
(79,264) |
216,871 |
|
8% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2022-12-13 |
4 |
OE |
$7.39 |
$585,761 |
D/D |
79,264 |
296,135 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-12 |
4 |
AS |
$46.75 |
$517,990 |
D/D |
(11,080) |
88,479 |
|
9% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-09 |
4 |
AS |
$46.15 |
$1,893,504 |
D/D |
(41,032) |
99,559 |
|
11% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-09 |
4 |
OE |
$13.08 |
$387,155 |
D/D |
29,599 |
140,591 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-03 |
4 |
D |
$46.60 |
$13,794 |
D/D |
(296) |
110,992 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
649 |
111,288 |
|
- |
|
Connors Nelda J |
Director |
|
2022-11-29 |
4 |
S |
$44.47 |
$809,243 |
I/I |
(18,196) |
27,246 |
|
-14% |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2022-11-18 |
4 |
S |
$42.72 |
$638,773 |
D/D |
(14,952) |
57,534 |
|
-16% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-11-15 |
4 |
AS |
$42.60 |
$71,483 |
D/D |
(1,678) |
94,913 |
|
16% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-11-07 |
4 |
AS |
$41.97 |
$5,280,997 |
D/D |
(125,827) |
1,767,665 |
|
16% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-11-07 |
4 |
OE |
$7.39 |
$1,176,011 |
D/D |
125,827 |
1,893,492 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-11-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
230 |
110,639 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-10-17 |
4 |
AS |
$40.52 |
$539,743 |
D/D |
(13,322) |
96,591 |
|
15% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-10-03 |
4 |
AS |
$39.34 |
$4,949,556 |
D/D |
(125,827) |
1,767,665 |
|
19% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-10-03 |
4 |
OE |
$7.39 |
$1,176,011 |
D/D |
125,827 |
1,893,492 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2022-10-02 |
4 |
D |
$38.73 |
$38,614 |
D/D |
(997) |
38,002 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2022-10-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,394 |
38,999 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-09-15 |
4 |
AS |
$42.21 |
$316,586 |
D/D |
(7,500) |
109,913 |
|
9% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-09-06 |
4 |
AS |
$40.49 |
$5,094,310 |
D/D |
(125,828) |
1,767,665 |
|
12% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-09-06 |
4 |
OE |
$7.39 |
$1,176,024 |
D/D |
125,828 |
1,893,493 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-08-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
365,457 |
1,767,665 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-08-15 |
4 |
AS |
$42.03 |
$315,260 |
D/D |
(7,500) |
117,413 |
|
10% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-08-08 |
4 |
AS |
$40.97 |
$5,154,682 |
D/D |
(125,828) |
2,133,122 |
|
12% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-08-08 |
4 |
OE |
$7.39 |
$1,176,024 |
D/D |
125,828 |
2,258,950 |
|
- |
|
4538 Records found
|
|
Page 16 of 182 |
|
|